Join the Alliance for Regenerative Medicine (ARM) as we present a captivating webinar series featuring distinguished executive leaders at the forefront of the cell and gene therapy sector. This engaging series is designed to shed light on the latest advancements, challenges, and transformative discussions shaping the future of regenerative medicine. Check back often as more webinars will be added to the schedule.
Speakers:
Mark Sawicki, Ph.D., CEO, Cryoport Systems (Moderator)
Natalie Sacarakis, Head of Cell and Gene Therapy Logistics, IQVIA Cell and Gene Therapy Center of Excellence
Narinder Singh, Chief Technical Officer, Arcellx
This webinar will bring together industry leaders to discuss the unique challenges and critical considerations in managing the temperature-controlled supply chain and logistics for CGTs. The conversation will highlight the complexities, regulatory requirements, and innovations necessary to ensure the safe and efficient delivery of these advanced therapies.
Speaker:
Delara Motlagh, Ph.D., Vice President, Global Cell Therapy and Plasmid DNA, Catalent
This webinar will explore the critical steps required to successfully bring cell and gene therapies to market. Experts will discuss strategies for navigating regulatory landscapes, securing funding, scaling manufacturing processes, and achieving market access. Attendees will gain insights into overcoming challenges and leveraging opportunities to ensure the commercial success of these groundbreaking therapies.
Speakers:
Behnam Baghbaderani, Ph.D., Vice President, Global Head of Commercial and Program Management, Lonza (Moderator)
Tom Klima, Chief Commercial and Operating Officer, bluebird bio
Kinnari Patel, Pharm.D., President and Chief Operating Officer, Rocket Pharma
This webinar brings together industry experts to illuminate the path forward in the dynamic landscape of regenerative medicine. Gain invaluable insights into the multifaceted journey of bringing these groundbreaking therapies to patients and learn from the experiences of those at the forefront of innovation.
Speakers:
Joe Judge, Executive Managing Director, JLL (Moderator)
Matt Jackson, Executive Managing Director, JLL
Christopher Vann, Chief Operating Officer, Autolus Therapeutics
In the rapidly evolving landscape of cell and gene therapies, determining the optimal manufacturing strategy is pivotal for success. This panel explores the strategic considerations behind the “Build vs. Buy” dilemma in manufacturing these innovative treatments.
